Potential Huntington’s Disease Gene Therapy Granted Expedited Patent Review – Huntington’s Disease News
Huntington’s Disease News |
Potential Huntington's Disease Gene Therapy Granted Expedited Patent Review
Huntington’s Disease News A patent application for Vybion's potential gene therapy for Huntington's disease (HD) and other neurodegenerative conditions has been granted Track One status by the U.S. Patent and Trademark Office (USPTO). Patent applications are ordinarily reviewed … |
